As cyber-attacks escalate worldwide, Sophos announced it will acquire SecureWorks for $859 million. The all-cash reverse triangular merger will combine the two cyber-security companies as they seek to ...

The cases are varied, but the allegations, generally, track each other – the meatpacking industry is highly concentrated, leading to allegations that prices for these important products are ...

Altogether, since October 2022 Womble Bond has filed 223 tobacco-industry-related FOIA requests, almost all with the FDA, according to PoliScio Analytics’ competitive-intelligence database FOIAengine, ...

Specifically, our guest talks about the EPA’s new PFAS Safe Drinking Water Final Rule, which mandates acceptable levels of PFAS in public water systems. This episode is based on a CLE webinar our ...

Artificial Intelligence (AI), is a decades-old field in computer science. Brad Myers, director of the Human-Computer Interaction Institute at Carnegie Mellon University, defines it as “a broad ...

Ecstasy, also known by the pharmaceutical shorthand MDMA (an abbreviation of 3,4-methylenedioxymethamphetamine), is used illegally by millions in the U.S. The synthetic drug has been banned since ...

Soon after emergency response teams scramble into action to address chemical fires, explosions, or other toxic events, attorneys begin gathering and analyzing information either to mitigate ...

According to DealPulse’s M&A database, which harnesses both AI and attorneys to digest the granular deal points of publicly-announced transactions, Acacia is advised by law firm Baker Botts L.L.P. and ...

Marsh & McLennan announced plans to acquire McGriff Insurance Services, a provider of insurance brokering and risk management services. The deal is structure as a reverse triangular merger ...

Does radiation from cell phones and cell towers affect human health? There has long been controversy around this question, which the federal government has tried to put to rest by issuing findings ...

Pharmaceutical giant Organon (NYSE: OGN) announced it will acquire Dermavant Sciences Ltd. from Roivant, in a private target merger valued at $1.2 billion. Under the terms of the merger agreement ...